MedTrace Logo

Metformin Effect on Fracture Healing in Post-Menopausal Women

NCT03845153 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-02-09

No results posted yet for this study

Summary

study the effect of metformin drug on fracture healing of patients with high risk of delayed fracture healing or non-union and correlating this to serum irisin myokine level.

Conditions

  • Bone Fracture

Interventions

DRUG

Metformin Retard 850 mg

tablet

OTHER

Placebo

placebo tablet

Sponsors & Collaborators

  • Damanhour University

    lead OTHER

Principal Investigators

  • Gamal Omran, Professor · Damanhour University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03845153 on ClinicalTrials.gov